Source: StreetInsider

Press Release: AbbVie : ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

New York, New York--(Newsfile Corp. - April 12, 2025) - WHY:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all persons or entities...

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Robert A. Michael's photo - CEO of AbbVie

CEO

Robert A. Michael

CEO Approval Rating

81/100

Read more